CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.
about
Modulation of tumor necrosis factor by microbial pathogens.Orthopoxvirus genes that mediate disease virulence and host tropismSubversion of cytokine networks by virally encoded decoy receptorsA survey of host range genes in poxvirus genomesOut of the Reservoir: Phenotypic and Genotypic Characterization of a Novel Cowpox Virus Isolated from a Common VolePoxviruses and the evolution of host range and virulenceAn interferon-gamma-binding protein of novel structure encoded by the fowlpox virus.A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologueThe complete genome sequences of poxviruses isolated from a penguin and a pigeon in South Africa and comparison to other sequenced avipoxvirusesGlycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins.A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.A secreted high-affinity inhibitor of human TNF from Tanapox virus.Poxvirus immunomodulatory strategies: current perspectivesComparative Biochemical and Functional Analysis of Viral and Human Secreted Tumor Necrosis Factor (TNF) Decoy Receptors.Oncolytic viral therapies.Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus.Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design.Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.Modified vaccinia virus Ankara can activate NF-kappaB transcription factors through a double-stranded RNA-activated protein kinase (PKR)-dependent pathway during the early phase of virus replicationA tumour necrosis factor receptor-like protein encoded by Singapore grouper iridovirus modulates cell proliferation, apoptosis and viral replication.Modulation of the host immune response by cowpox virusHow vaccinia virus has evolved to subvert the host immune response.Viral interference with innate immunity by preventing NF-κB activity.Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.Inhibition of interferons by ectromelia virus.Genetic variability of immunomodulatory genes in ectromelia virus isolates detected by denaturing high-performance liquid chromatography.Poxviruses Utilize Multiple Strategies to Inhibit Apoptosis.Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.Challenges and Achievements in Prevention and Treatment of Smallpox.Variation in ligand binding specificities of a novel class of poxvirus-encoded tumor necrosis factor-binding protein.Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation.
P2860
Q21089629-81CEB432-E096-43DD-A354-B59B66A043F1Q21285044-BE555C5F-DE98-4CAC-B6A7-CF0505F0EE8FQ27005694-151058A0-E261-4748-B849-9506A5B32B83Q28389388-16B5327E-44E4-4965-B86B-BF3A9D73DC66Q28608426-1D3069D8-AAF1-4323-A53B-BBD4C72E054AQ28658130-E9F7DCFE-4FD7-4097-A8F2-AA57BF1FC4B9Q31121628-313C922F-4810-441F-A420-1F58E75B4C6CQ33429965-B7F0CC9C-4A3E-427E-BA75-73ED4C7A44E8Q34032643-C2F19F3A-8F81-46EE-8E02-49E5F57554F2Q34500793-3E88734C-4145-4AAA-8087-29BD1E19FB1CQ34583194-8112F446-CD55-411F-8211-B371319DE306Q34596242-DC2F6F97-5B8E-4AD8-B4F4-EE9EA1728F3AQ34960958-D2A135F9-B058-4625-8176-07E1E5FA1F5DQ35125981-EAB65164-2EC0-44FA-897C-15673A38FCF0Q35783059-5CD00997-157E-4AC4-9263-A6D6F39BA0FBQ35852258-B41D22E0-4D0F-4DC6-AFCE-DB43578E2803Q36371279-5ACF6FEF-66A5-409E-81F3-7BC4C9665402Q36728801-6332F748-F9EE-4096-83A6-7DEE3E01416EQ37382604-2EAF2AC6-1000-45A9-93B7-B10315C45F5EQ37395304-641A9922-B349-4766-9134-CF419EBA9466Q37738397-9F987E38-2A79-4BD8-AF11-5EB0685071E2Q37776790-863C8CF2-8285-47DE-920D-7F9D1543D884Q37855047-22E80C71-729A-4C63-9825-A5A0BF566583Q37952350-A8F65DC0-ED74-460F-A1E8-46F9A7F43A99Q39059671-61FF9362-3882-4390-AA62-B7AF6F7B0F61Q39682117-BC9618CF-E5E9-4B7A-9D69-1E4774B0B789Q39996553-0F87AF4F-01EB-4289-A3C5-1F6BB5490311Q40090965-0039CD5B-0E0F-437F-8CF3-7786BB9B13A0Q40560199-F341ADC7-95A1-48AB-99F0-041F3B08698AQ47547852-DD351917-73E3-457B-B815-C6E13915163DQ52669186-50931CEB-AB19-4A89-B50F-9D31DBDAABE7Q55256270-5A27885D-B813-4E96-9194-13C5C5529594
P2860
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.
@ast
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.
@en
type
label
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.
@ast
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.
@en
prefLabel
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.
@ast
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.
@en
P2860
P1433
P1476
CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses
@en
P2093
P2860
P304
P356
10.1128/JVI.75.1.226-233.2001
P577
2001-01-01T00:00:00Z